Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Julio Delgado María Rozman Marta Aymerich Emili Montserrat |
| Publication date | October 12, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |